Prot# 191622-104: A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Extension Study to Evaluate the Safety and Efficacy of BOTOX (Botulinum Toxin Type A) Purified Neurotoxin Complex in Subjects with Facial Rhytides (Crow's Feet L

Project: Research project

StatusFinished
Effective start/end date2/22/1110/3/12

Funding

  • Allergan, Inc. (191622-104)